Health-related quality of life in patients with heart failure eligible for treatment with sacubitril-valsartan
- PMID: 32089852
- PMCID: PMC7024611
- DOI: 10.1002/nop2.420
Health-related quality of life in patients with heart failure eligible for treatment with sacubitril-valsartan
Abstract
Aim: To describe and compare self-reported health-related quality of life between younger and older patients with severe heart failure eligible for treatment with sacubitril-valsartan and to explore the association between health-related quality of life and age, NYHA classification, systolic blood pressure and NT-proBNP level.
Design: Cross-sectional study.
Methods: A total of 59 patients, eligible for treatment with sacubitril-valsartan were consecutively included and divided into a younger (≤75 years) and older group (>75 years). Health-related quality of life was assessed using the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5-dimensions. Data were collected between June 2016 and January 2018. The STROBE checklist was used.
Results: There were no differences in overall health-related quality of life between the age groups. The older patients reported lower scores in two domains measured with the Kansas City Cardiomyopathy Questionnaire, namely self-efficacy (67.0 SD 22.1 vs. 78.8 SD 19.7) and physical limitation (75.6 SD 19.0 vs. 86.3 SD 14.4). Higher NYHA class was independently associated with lower Kansas City Cardiomyopathy Questionnaire Overall Summary Score.
Keywords: health‐related quality of life; heart failure; self‐care; self‐efficacy.
© 2019 The Authors. Nursing Open published by John Wiley & Sons Ltd.
Conflict of interest statement
KL has received lecture grants from Novartis. For the remaining authors, none were declared.
Similar articles
-
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.JAMA. 2021 Nov 16;326(19):1919-1929. doi: 10.1001/jama.2021.18463. JAMA. 2021. PMID: 34783839 Free PMC article. Clinical Trial.
-
Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction.JACC Heart Fail. 2021 Jan;9(1):42-51. doi: 10.1016/j.jchf.2020.09.012. Epub 2020 Nov 11. JACC Heart Fail. 2021. PMID: 33189630
-
Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes.JACC Heart Fail. 2021 Feb;9(2):137-145. doi: 10.1016/j.jchf.2020.09.014. Epub 2020 Dec 9. JACC Heart Fail. 2021. PMID: 33309581
-
Efficacy and Safety of Sacubitril/Valsartan Compared With ACEI/ARB on Health-Related Quality of Life in Heart Failure Patients: A Meta-Analysis.Ann Pharmacother. 2023 Aug;57(8):907-917. doi: 10.1177/10600280221140575. Epub 2022 Dec 8. Ann Pharmacother. 2023. PMID: 36475871
-
Effects of sacubitril/valsartan in patients with heart failure and chronic kidney disease: A meta-analysis.Eur J Pharmacol. 2020 Oct 5;884:173444. doi: 10.1016/j.ejphar.2020.173444. Epub 2020 Jul 30. Eur J Pharmacol. 2020. PMID: 32739172
References
-
- Buck, H. G. , Dickson, V. V. , Fida, R. , Riegel, B. , D'Agostino, F. , Alvaro, R. , & Vellone, E. (2015). Predictors of hospitalization and quality of life in heart failure: A model of comorbidity, self‐efficacy and self‐care. International Journal of Nursing Studies, 52(11), 1714–1722. 10.1016/j.ijnurstu.2015.06.018 - DOI - PubMed
-
- Buck, H. G. , Lee, C. S. , Moser, D. K. , Albert, N. M. , Lennie, T. , Bentley, B. , … Riegel, B. (2012). Relationship between self‐care and health‐related quality of life in older adults with moderate to advanced heart failure. Journal of Cardiovascular Nursing, 27(1), 8–15. 10.1097/JCN.0b013e3182106299 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials